Sunday, August 6, 2017
Home »
» Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
11:45 PM
No comments
Related Posts:
Open Access Article: Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer Open Access Article: Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer … Read More
New Issue Published Current Cancer Drug Targets Vol 17 issue 5 … Read More
Free Trial Request Free Trial Request … Read More
Most Accessed Article Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies Most Accessed Article : Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies … Read More
Call For Paper Call For Paper … Read More
0 comments:
Post a Comment